DEVELOPED
MARKETS

As the largest player in the Turkish pharmaceutical industry, Abdi İbrahim exports its products to 60 countries through out licensing in developed markets, distributors and joint product development with leading firms. Furthermore, Abdi İbrahim markets European products via its Portuguese subsidiary Abdi Farma. Abdi İbrahim engages in out licensing operations in Europe, Canada and Australia, enhancing its market presence with European-standard products developed and produced in its EU GMP certified production facility in Istanbul. In addition to out licensing, Abdi İbrahim also sells Abdi Farma licensed products in various European countries via distributors. The company also continues joint product development with various leading pharmaceutical companies.